Stringers
Mobile App · iOS · written 11-15
Nlog - 不妊治療記録 · kaori hoshino

In the same summer, 6 people built fertility-treatment tracking apps, and only she broke through: Nlog wasn't won by features

What it is: a Japanese app for tracking fertility treatment. Clinic visits, medication reminders, and costs (insurance and out-of-pocket kept separate, split between spouses) live in one place, shareable to a husband with one tap over LINE. Local storage, no login, no ads. Advanced features are a ¥300 subscription.

Why it took off: the developer was herself a patient. Before launch she recruited beta testers in Threads' 妊活 (fertility) community. One post got 17.9k views and 134 replies, which gave her the first real users and reviews. The title used the category term, so four core search terms ranked first. In three and a half months she shipped about 20 updates responding to feedback. In November she added basal body temperature and expanded to people trying to conceive, and ratings started climbing faster.

CHow you could follow it Don't build another Japanese or Korean fertility tracker. If you're going through something private that you have to explain to family (chronic illness, dialysis, caregiving), copy the approach: before launch, recruit testers in the community as someone living it, use the community's search terms in the title, share with one tap to the local chat app, and ship updates often.

Grade C: she probably makes only tens of thousands of yen a month. Japan's search top spot is already taken by her, and three or four similar apps have appeared in Korea this year. She won because the developer is a patient and has trust in the community, which followers can't copy. What you can learn is the playbook: cold-start as someone living the problem, use search terms, iterate fast. Buzz in the small circle

Est. monthly revenue (App Store) under $1KWe estimated this from its chart ranks and rating growth across storefronts, calibrated against verified revenue; typical error is 2–3x. Read it as a tier, not an exact number.

Data (updated daily) · first listed 2026-07-27 · Japan rating 55 · charted in 11-19 of 1 stores
iOS · best category chart rank · by store
10020010-2811-0211-0711-1111-19146
Data 2026-10-28 → 2026-11-19 (23 days, 17 observations). Lower rank is higher; gaps mean it wasn't charted that day
iOS · rating count · Japan
203040506010-2811-0211-0711-1111-1955
Data 2026-10-28 → 2026-11-19 (23 days, 17 observations). Apple doesn't publish download counts; rating growth is a proxy for downloads.

A solo developer in Japan going through fertility treatment posted on Threads in July 2026: "I'm building this app and looking for testers." Three and a half months later, her app Nlog ranked #1 for 「不妊治療」 in the Japan App Store, had 50 ratings averaging 4.7 stars, and for the first time squeezed into the top 50 of the Medical free chart. The pool is small, but at least five or six others built nearly the same thing that summer, and their ratings stayed in single digits. This piece covers what she got right, how much money is in it, and whether you can take this path.

The July 27 post

On July 27, 2026, the Threads account @hosh_i318 (the name is just 「星」) posted under the #不妊治療 tag:

"I'm developing a simple app for recording fertility treatment and sharing it with your partner!"

She went on to explain why: three problems of her own. She wasn't recording things properly; she had to explain everything to her husband out loud every time, which was exhausting; and she'd never clearly tracked how the costs were split. Then the ask: she wanted people willing to test it, give feedback, and suggest improvements. "If you're willing to try it, just reply." The last line was "(will anyone reply to me... so nervous...)"

At that point the app was still waiting on App Review. By mid-November the post had 17.9k views, 358 likes, and 134 replies (Threads, 11-15). That evening she posted again: "Just opened Threads and saw so many replies, I was startled... I'll reply to each one."

The replies are real people: "September I'm starting IVF, and couples have to talk about how costs get split, I really want this! I'm a systems engineer, happy to help if I can"; "I was just looking for an app to track expenses"; "Every time I spend something I have to report it myself, and the little things are a pain to explain... I definitely need this." On Jul 29 the app was approved, and she went back under every reply and posted the download link. One person who installed it that same day replied: "Being able to send the visit records to my husband over LINE is so useful!"

She was a patient herself, and the people she recruited were patients in treatment too. That was the starting point for everything that came after.

What it does

Nlog does one thing: it keeps the visits, medications, and expenses of fertility treatment in one place, then sends them to the husband over LINE with one tap.

  • Visits: designed around the IVF process as options. Day of cycle, transfer day, how many eggs were fertilized and frozen after retrieval, embryo grade, and a dozen-odd hormone blood test values, all selected with taps. An August comment said: "When you're really down during treatment, writing records yourself is painful. Being able to pick from options helped a lot."
  • Medications: oral, self-injected, and vaginal medications are tracked separately, with daily reminders. One tap marks a dose as taken.
  • Costs: the September version separates insurance, out-of-pocket, and advanced medical care, showing "paid, refunded, and actual burden," summarized by month or by cycle. Many Japanese couples keep their wallets separate and settle accounts monthly. In a reply she said the design was built around exactly that setup.
  • Sharing with the husband: rather than asking the husband to install the app, it sends straight over LINE. She explained in a reply: "I thought about having my husband install the app to sync, but he'll definitely read LINE, and it's almost real-time."

Three more things made it feel safe to this audience: data stays only on the phone, no login is needed, and there are no ads. The icon also doesn't reveal fertility treatment. One comment said: "It's not embarrassing to keep on my home screen."

Money came later. Her July post said "free download, no ads, no in-app purchases." In Sept 30 she added a paid tier, Nlog Plus, listed at ¥300 in the store as an auto-renewing subscription. It buys advanced features like medication alarms that keep ringing until you turn them off, and photo attachments. Basic recording stays free. As early as August someone commented: "Paying is fine, I'd just like a medication alarm added." For comparison, the long-established Lunaluna temperature notebook puts fertility-treatment tracking inside a ¥580/month paid course, and ninpath's consultation package costs ¥980/month.

How big it is now: very small, but growing

DateJapan cumulative ratingsBest Medical-category rank
10-2827Top Grossing 128
11-0227Top Grossing 97
11-0728Top Grossing 92
11-1131Top Grossing 183
11-1648Top Free 45

(App Store Japan storefront, daily tracking; 11-15 store page shows 50 ratings, 4.7 stars, Medical free chart #31)

From late October to Nov 10 it barely moved. From Nov 11, 5 days later it had about 20 more ratings, and it entered the Free chart's top 50 for the first time. The v1.1.20 update shipped on Nov 13 added basal body temperature and a chart, and you can log bleeding, mood, ovulation tests and pregnancy test results. That step widened the users from "already in treatment" to "self-tracking and trying to conceive", and the inflection lines up with it (inference). It could also be the new version's system rating prompt; I can't confirm which.

Revenue: since late October it has sat between roughly 92 and 200 on the Japan Medical Top Grossing chart, which implies a trickle of subscriptions every day. The bar for that chart is low, and monthly revenue is likely under tens of thousands of yen (estimate, no external data). It's iOS only in Japan with no Android version. In October it opened the US storefront, but the interface is Japanese only.

Where users come from

Threads' fertility-journey community. That was the whole cold start. After that post, every update went out on Threads as an "update notice," tagging the people who had asked for the change. The account has only 196 followers so far, but the community is small and tight-knit, and a single post there can still reach 10,000+ people.

App Store search. Title it with the category keyword: 「不妊治療記録」. Nov 15, search the Japan store for 「不妊治療」「不妊治療記録」「体外受精」「妊活記録」, and it ranks #1 for all of them (iTunes search API, 11-15). Niche keywords have little competition, so a few dozen reviews is enough to hold the top spot. The audience is sizable: Japan ran 562k assisted reproduction cycles in 2023, and 1 in every 8.6 newborns is born via IVF, 1 (Japan Society of Obstetrics and Gynecology). Insurance has covered treatment since 2022, but with age and cycle caps, and insurance, self-pay and advanced medical care often get mixed together, so tracking costs is a real need.

Fast release cadence. From late July to Nov 13, about 20 versions shipped, many of them directly answering reviews: medication reminders, calendar weeks starting on Sunday, separating insurance from self-paid costs, and not having to re-enter medications used in the past. The most common kind of review comment reads: "I asked for things a few times and reported bugs, and they changed them really fast... it feels great to be heard" (11-04). The latest Nov 14 review: "Data had problems before, but they fixed it quickly and carefully."

What's missing is also worth noting: no evidence of paid ads, no media coverage, no X accounts writing about it, and it isn't in the clinic-recommended "9 fertility treatment apps" list (October).

Same idea, at least 6 people are building it

Fertility treatment record apps in Japan fall into three tiers.

Big players and veterans: ルナルナ (58k ratings), ラルーン (46k), and Flo (31k) focus on cycle and ovulation prediction, and don't cover IVF procedures, medications, or costs. ルナルナ体温ノート's fertility treatment course requires signup and a monthly fee of ¥580. ninpath, an older product focused on fertility treatment (2020 years, 80 rating, 3.9 stars), pitches "compare with others' data," requires an account, and reviewers say the stats are hard to understand. cocoromi (25 ratings, 2.2 stars) also leans toward a data platform. Clinics' own apps only record data for that clinic, not costs.

The real competitors are the same wave of indie developers:

AppLaunchedRating (Japan store)Notes
不妊治療の記録 (LEAN ASIA)2026-060Translated from English, emphasizes not sharing data
Fertility Tracker2026-070Receipt scanning with OCR and PDF export, heavier feature set
あんしん不妊治療費の記録2026-071Only handles costs and subsidy applications, one-time purchase ¥300
エフレコ2026-082Nearly identical positioning, not updated since September
Hug 不妊治療記録・共有2026-09-287Launched two months after Nlog, nearly copies its selling points, adds Android and real-time sync for couples
Ivy2026-10-302Community plus records

(App Store Japan, as of mid-November)

Feature-wise, Nlog has nothing others couldn't build, and several are stronger. The gap lies elsewhere: the others didn't show up in any community after launch, and many weren't updated much; Nlog had a group of patients who followed it from day one, wrote it good reviews, and requested features, which got it to #1 in search. Top search rank then brought in steady new users, and frequent releases kept them.

What about other countries: someone is already doing it in Korea

Searching 난임 기록 (infertility record) in the Korean App Store, the top results are also individual apps launched this year: 페어오라 (2026-03,23 ratings), 베베로드 (2026-06,13), and Folli (2026-06,2), plus Korean versions of the Japanese peers above (App Store Korea, 11-15). The idea of "IVF record + share with partner" was independently arrived at by many people in 2026, and neither Japan nor Korea is empty anymore. In Taiwan, searching 試管嬰兒 (IVF) turns up only clinic apps and mainland Chinese community apps, with no similar product, but the market is much smaller.

If it were you

C. There's something to learn, but copying it isn't very profitable. Nlog's own monthly revenue is estimated at tens of thousands of yen, and both Japan and Korea already have a batch of similar apps. Its edge is that the developer is a patient herself and has trust in the community, which others can't simply copy. What's worth taking is the playbook.

  • Who it's for: people going through a private, high-frequency, expensive situation they have to explain to family, who cluster on a particular social platform: fertility treatment, chronic illness, dialysis, children's allergy or developmental clinics, elder care, pet medical care. You need to be personally going through it; that's the prerequisite.
  • Who it's not for: anyone wanting to build yet another Japanese or Korean fertility treatment record app. Search #1 in Japan is already taken, and copycats like Hug have 7 ratings; Korea has also seen three or four show up this year. It's also not for people who aren't patients and want to win on a more complete feature set: Fertility Tracker has more features, and its rating is 0.
  • How to build it: The app does only three things: turns that process into tap-to-log records, reminders, and cost summaries, plus one-tap sharing to the chat app locals use daily (LINE in Japan, KakaoTalk in Korea). Data stays local, no login, no ads. Keep everything free at first; once reviews say "I'd pay for X feature," put that feature into a subscription priced half of the veterans'.
  • How to acquire users: Before launch, post in the community's usual platform, in the voice of someone going through it, something like "I'm building this, looking for beta testers," and spell out the three pain points you're solving. Reply to every comment; on launch day, return to each reply and drop the link. Use the search terms that community uses for the title. After that, post an update notice for every release, tagging the people who asked for changes. For the first three months, aim to ship a version every week.
  • When to move: Trust in these communities goes to whoever arrives first. Where someone already has the same idea, arriving two months late (like Hug) means only scraps. Before you start, search the local store: if the top three already include an indie developer who updates often, pick a different niche.
  • Signs you got it wrong: ① By 2027 February, Nlog's Japan rating is still below 100 and it drops out of the top 200 on the top-grossing chart, which means this path is a tens-of-thousands-of-yen side business that can't sustain even when expanded to the trying-to-conceive audience; ② Hug matches Nlog's rating by offering Android and couple sync, which means community trust doesn't hold and features and platform coverage win; ③ You post "looking for beta testers" in your own community and get fewer than 20 replies, meaning the niche isn't painful enough or the people aren't on that platform. Don't force it.

iOS store page ↗

Research notes: competitor table, acquisition evidence, full research report
Competitors
NameWhereLaunchedScaleHow it differs from this one
ルナルナ 体温ノート 不妊治療サポートコース (MTI)Big-company features2013 (App); treatment course about 20196,243 ratings, +18 in 7 days (appstore library)Centered on basal body temperature; treatment records sit in a paid course at ¥580/month requiring membership. Nlog's core features are free and login-free, designed around the IVF process and cost splitting.
ルナルナ / ラルーン / FloiOS2010 / 2011 / 201558k / 46k / 31k ratingsCycle and ovulation prediction app; doesn't cover IVF medications, tests, or costs
ninpathiOS2020-1280 ratings, 3.9 stars; has an Android versionSelling point is comparing against third-party treatment data, plus a consulting package at ¥980/month. Requires an account, and reviewers say the stats are hard to understand. Nlog only handles your own records and sharing with your partner.
cocoromi(vivola)iOS2021-0425 ratings, 2.2 starsData platform, shows treatment outcomes for similar populations; poor experience
Hug 不妊治療記録・共有iOS2026-09-287 ratings; medical top-grossing rank 81–191Copycat; real-time couple sync and Android, but no community trust or search ranking
エフレコ / Fertility Tracker / あんしん / IVFDiary(LEAN ASIA)iOS2026-06 to 2026-080–2 ratings eachSimilar features, some heavier (OCR, PDF export); but no community presence, rarely updated after launch, didn't take off
Ivy(PRISM)iOS2026-10-302 ratingMainly fertility treatment community and experience sharing; records are a side feature
Kirokudo Net, clinic-specific in-house appsOther2018–2026Dozens of ratings eachProvided by clinics; only records that clinic's data, no costs, doesn't work across clinics
Where users come from
  • Verified Threads fertility-community build-in-public: 2026-07-27 post "I'm developing a simple app that lets you record fertility treatment and share with your partner... looking for people to give feedback," 17.9K views, 358 likes, 134 replies. The developer replied to each one and posted the link at launch; every update since has gone out as an announcement (threads.com/@hosh_i318)
  • 查实 App Store 搜索(ASO):标题用品类词;日本区搜「不妊治療」「不妊治療記録」「体外受精」「妊活記録」都排第 1(iTunes Search API 2026-11-15)
  • Verified Word of mouth / positive reviews and fast iteration: From 7-27 to 11-13, about 20 versions, most directly responding to requests in reviews; app-ranking.net puts review sentiment at 92% positive, with reviews mentioning "意見反映が早い" (feedback is reflected quickly)
  • Inferred Feature expansion (v1.1.20 adds basal body temperature and ovulation records): After 11-13 shipped, 11-12 to 11-16 added 17 ratings, and it entered the medical free chart at #45/31 for the first time; the causal link is inferred
  • Verified X: Only scattered users posting screenshots with #Nlog, plus automated ranking posts from the @AppRankNavi bot 11-07; no big accounts
  • Inferred Paid ads: Ad libraries don't track it (each platform is marked "not checked"), and no evidence of ad spend was found

Why Nlog - 不妊治療記録 (iOS, Japan) made it

Data as of 2026-11-16. App Store data = our appstore database (DuckDB on the agent-im machine); other items link to their sources.

Bottom line

Nlog is a fertility treatment record app built by an indie developer in Japan who is going through treatment herself (Kaori Hoshino, Threads @hosh_i318). It keeps visits, medications, and costs in one place and sends everything to her husband via LINE in one tap. Its pond is small: it's a real hit, just at a very small scale: in 3.5 months since launch it has 50 ratings, and it made the medical free chart for the first time, reaching #31–45.

It took off because of three things:

  1. On launch day, it posted "I'm building this, looking for beta testers" in Threads' fertility-journey community, getting 17.9K views, 358 likes, and 134 replies, which brought in the first batch of seed users;
  2. 在 App Store 日本区搜「不妊治療」「不妊治療記録」「体外受精」「妊活記録」,它都排第 1,吃下了商店搜索的自然流量;
  3. It shipped releases almost daily based on reviews and Threads feedback, with about 20 versions in 3.5 months, and the reviews are almost all praise like "they respond to feedback quickly."

Its differentiator is "designed specifically for people doing IVF/IUI + cost splitting + sending to a husband via LINE + no login, data stays on the phone." That gap is part of why it worked, but in the same summer at least 5 other indie developers built nearly the same thing, and none of them took off. What really set it apart is that the developer is a patient herself with trust in Threads' fertility community, plus #1 search ranking and fast iteration.

1. Data: how big it is now

DateCumulative ratings (JP)New todayBest Medical-category rank
2026-10-2827–Top Grossing 128
11-02270Top Grossing 97
11-07281Top Grossing 92
11-11313Top Grossing 183
11-164817 (11-12 to 11-16 combined)Free chart #45

Source: appstore library, app_day. The App Store page 11-15 showed 50 ratings, averaging 4.7 stars, and "ランキング 31位 メディカル" (Top Free).

  • From late October to Nov 10, there were basically no new ratings. Growth clearly accelerated from 11-11, adding about 20 ratings in 5 days, and at the same time it entered the top 50 of the medical free chart for the first time. This inflection point coincides with v1.1.20 (released 11-13): this version added basal body temperature and charting, and can record bleeding, discharge, mood, ovulation test strips, and pregnancy test results. The feature set expanded from "people already in treatment" outward to "trying-to-conceive people who test their own temperature and ovulation" (see the App Store page for release notes). The rating jump of 17 might also be explained by a system rating prompt added in the new version; with 50 ratings but only a dozen or so text reviews, the explanation holds, but not verified.
  • It has revenue, just a small amount. 9-30's v1.1.11 added a paid tier, "Nlog Plus," listed at ¥300 on the App Store page. The privacy policy says it's an auto-renewing subscription managed through RevenueCat (https://hoshi-318.github.io/nlog-privacy/privacy-policy.html). Since 10-28 it has stayed on the Japan iOS Medical Top Grossing chart at around #92–200 (appstore library), which suggests a trickle of subscriptions every day. The Japan Medical Top Grossing bar is low, so monthly revenue is probably under a few tens of thousands of yen (unverified).
  • Only on the Japan iOS store. 10-20's v1.1.16 opened the US store, but the interface is Japanese only and Plus can only be bought in Japan, so there's no data for the US store. No Android version.

2. Competitors: who else does the same thing

App Store 日本区搜「不妊治療」「不妊治療記録」「体外受精」「妊活記録」四个词,Nlog 都排第一(iTunes Search API,2026-11-15)。

Big companies and established products (they focus on cycles / trying to conceive, with infertility treatment only as a side feature)

ProductLaunchedScaleHow it differs from Nlog
Lunaluna Body Temperature Note (MTI) "Infertility Treatment Support Course"20136,243 ratings, +18 in 7 daysCore is basal body temperature; treatment records sit in a paid course at ¥580/month, and you have to register as a member
ルナルナ / ラルーン(Medley)/ Flo2010 / 2011 / 201558k / 46k / 31k ratingsPeriod and ovulation prediction app that doesn't cover the IVF process, medication, or costs
ninpath(ninpath Inc.)2020-1280 ratings, 3.9 starsFocused only on infertility treatment, selling "compare with third-party data," plus a ¥980/month consulting package. Requires an account; reviews say the stats are hard to understand and that it feels like a company collecting data
cocoromi(vivola)2021-0425 ratings, 2.2 starsShows "treatment data from people like you," leaning toward a data platform
ママケリー(KINJIRO)2018375 ratingMulti-mode women's health app where infertility treatment is just one mode
コノトキ(amane factory)2020795 ratingCouples' trying-to-conceive app centered on ovulation prediction
Clinic systems like Kiroku Doi Net, and each clinic's own app (Kato, Asada, etc.)2018–Dozens of ratings eachProvided by the clinic; only records data from that clinic, not across clinics, and doesn't track costs

A wave of solo devs (launched 2026–6 in October, almost the same idea)

ProductLaunchedRatingNotes
Infertility Treatment Records (LEAN ASIA / IVFDiary)2026-06-090Translated from English, emphasizes "not shared with anyone"
Fertility Tracker(Tsuyoshi Ikeno)2026-07-210Uses OCR to read receipts, exports CSV/PDF, heavier feature set
あんしんInfertility Treatment Cost Records (Kei Konuma)2026-07-281 (2 points)Only handles costs and subsidy applications; one-time purchase ¥300
エフレコ(Ryota Watanabe)2026-08-172Almost identical positioning; not updated since 9-20
Hug Infertility Treatment Records & Sharing (Hiromu Koumi)2026-09-287Launched two months after Nlog, with a title and selling points that nearly copy it (sharing with a partner, medication, costs). Built as real-time two-person sync, available on iOS and Android. In the App Store "customers also bought" section, the first one is Nlog. Ranked #81–#191 on the Medical Top Grossing chart.
Ivy (PRISM GK)2026-10-302An infertility treatment community plus records

Takeaway: This space isn't empty. Big companies only covered the cycle layer, and the older product built specifically for the IVF process (ninpath) has poor UX. In summer 2026, at least 6 individual apps appeared around the same idea, and only Nlog took off.

3. Growth tactics: where users come from

  1. Threads 妊活圈 build-in-public(已确认,主要的冷启动来源)。 7-27 是 App Store 记录的上架日;开发者当天在 Threads 发帖「不妊治療の記録とパートナーへの共有ができる、シンプルなアプリを開発しています!……使ってみて感想をくれる方を募集」,顺带讲了自己的三个痛点:没好好记录、每次向丈夫口头解释很累、费用分摊糊里糊涂。这条帖子 17.9K 浏览 / 358 赞 / 134 回复。开发者一条条回复,7-29/30 上线后又回到每条回复下面贴下载链接(https://www.threads.com/@hosh_i318/post/DbSfIIkEVIr)。回复里有「9月から体外受精予定で…是非利用したい」「费用记录、正在找这样的 App」这类真实需求。现在账号有 196 个粉丝,置顶帖 10-03 发,之后每次更新都发「アップデートのお知らせ」,并感谢提要求的人(https://www.threads.com/@hosh_i318)。也有别人自发转:「えー!すごい!不妊治療始めたら絶対使おう」(@___nail.99)。
  2. App Store search / ASO (confirmed). The title is the category term 不妊治療記録 (fertility treatment log), and all four core search terms rank #1 (see above). Japan's infertility patient pool is large enough to bring steady organic installs: 2023 years of ART treatment 562k cycles, and one in every 8.6 babies born is 1 from IVF (JSOG ART data, www.denentoshi-lady.com/blog/878); insurance coverage started in 2022 April, with the out-of-pocket share at 3 in the window, but there are age and cycle caps, and self-pay and advanced medical care often get mixed together, so bookkeeping demand is strong (https://seishoku-clinic.com/blog/apps-for-fertilitytreatment/).
  3. X (very weak). The only scattered posts I found via Yahoo real-time search: one user posted a screenshot with #Nlog; the bot account @AppRankNavi automatically posted 「TOP100で戦う個人開発アプリ」 (around 11-07) listing Nlog. No major accounts have written about it.
  4. Paid acquisition: no evidence found. Our ad library doesn't track it (Meta/Google/TikTok/Apple Search Ads are all "not checked"). Given the size and approach of an individual developer, it probably didn't spend, but unverified.
  5. Media and clinic recommendations: none. The Seishoku Clinic Kinshicho branch's "9 infertility treatment apps" list from 2026-10 doesn't include it; it features ninpath, Lunaluna, etc. Only auto-aggregator sites like AppGeo indexed it on the day of launch.
  6. TikTok: not checked (TikHub balance insufficient). Japan's fertility community is mainly on Threads and Instagram, so TikTok promotion is unlikely, unverified.

4. Why users stay and why they pay

  • Structured input designed for the IVF process. DAY counts, ET/BT, post-retrieval fertilization and freezing counts, embryo grades, ten blood tests including E2/LH/FSH/AMH, nasal sprays, vaginal medications, self-injections... all selectable. A review says: 「治療中の辛い気持ちの時に自分で記録をつけるのは辛かったので、選択式で入力できてとても助かります」.
  • Cost splitting plus sending to the husband via LINE. 9-03's v1.1.5 records insurance, out-of-pocket, and advanced-medicine costs separately, and shows "paid / refunded / actual burden." This fits the Japanese couple's "separate wallets, monthly settlement" setup, and the developer said in Threads replies that it was designed around this.
  • Privacy and lightness. Data stays on the phone, no login, no ads. Reviews say the icon "doesn't look like infertility treatment," so it's not awkward on the home screen.
  • Fast iteration, and it's built by a patient. 7-27 to 11-13 saw about 20 versions, many directly responding to requests in reviews: medication alarms, a calendar starting Sunday, separating insurance and out-of-pocket costs, photo attachments, and more. Reviews include 「意見反映が早い…聞いてもらえた!と嬉しくなります」; app-ranking.net puts positive sentiment in reviews at 92% (https://www.app-ranking.net/id/6784057647).
  • Restrained monetization. Basic recording is free; advanced features like medication alarms that ring until manually turned off and photo attachments sit in the ¥300 Nlog Plus subscription, cheaper than Lunaluna (¥580) and ninpath (¥980). Early reviews already said 「有料でもよいので、お薬アラーム…」, showing people are willing to pay.

5. Was differentiation why it took off?

  • Only half the story. The combo of "IVF-specific + costs + partner sharing + local storage" is also offered by contemporaries like Efreco, Fertility Tracker, and Anshin, and later Hug, some of which are stronger (OCR, real-time two-person sync, Android).
  • What really separated it is distribution and trust: the developer is a patient who recruited trial users on Threads in a patient's voice, earning the first seed users and real feedback. Those users left good reviews and ratings, pushing it to #1 in search. Search ranking then drove steady organic downloads, and high-frequency iteration kept new users. Other individual apps never showed up in the community and mostly stopped updating after launch, so their ratings stalled at 0–7.
  • The November acceleration looks like v1.1.20 added basal body temperature and ovulation records, widening the audience from "already in treatment" to "early trying to conceive" (inferred).

6. How many people know it

  • No media coverage, no major X accounts have written about it, and revenue hasn't been disclosed (no TrustMRR listing or founder revenue posts).
  • Spread only within Threads' infertility-treatment circles; the developer account has 196 followers.
  • Copycats have already appeared: Hug (2026-09-28), with a highly similar title and selling points, plus Android and two-person sync.

7. What others can learn

  1. Find scenarios you're personally going through, where the audience is concentrated and the topic is private (infertility treatment, chronic illness, dialysis, pet medical care...), and post in the topic circles on Threads / Instagram as someone living it: "I'm building this, looking for people to try it." In Japan, Threads' topic circles are receptive to posts like this, and one post can gather hundreds of seed users.
  2. Use the category term directly in the title (「不妊治療記録」). Niche terms have little competition, and a few dozen good reviews can get you to #1.
  3. Turn "explaining it to a partner / family" into one-tap sharing, using the dominant messaging app in the target market (LINE in Japan). The shared content itself helps it reach more people.
  4. Local storage, no login, no ads to lower the guard of a sensitive audience. Core recording is free, and advanced features like reminders and attachments are charged through a low-priced subscription.
  5. Requests from reviews and social media get a release every few days, and the requesters get publicly thanked on social platforms, turning users into co-builders.

8. Still unclear

  • Real download counts and revenue. There's no external data on how many downloads or how much revenue the Medical Free chart rank of #31–#45 and Top Grossing rank of #92–#200 correspond to. Estimate: a few dozen downloads a day and monthly revenue under tens of thousands of yen, unverified.
  • Between 11-12 and 11-16, these 17 ratings: whether it's organic growth from the new version, a rating prompt being added, or a Threads post going viral, I couldn't confirm (logged-out Threads only shows the most recent few posts).
  • Whether Apple Search Ads were run in the Japan store; the ad library doesn't cover it.
  • Whether Nlog Plus is billed monthly or yearly; the store page only shows ¥300.
  • Whether the US store launch got any traction (the interface is Japanese only, so likely not).

This article was written by AI from public data and the data we collect daily. Numbers are sourced, and inferences are labeled.